Current therapeutic delivery approaches using nanocarriers for the treatment of tuberculosis disease
Tuberculosis is a major health issue globally and a leading cause of death due to the
infective microorganism Mycobacterium tuberculosis. Treatment of drug resistance …
infective microorganism Mycobacterium tuberculosis. Treatment of drug resistance …
[HTML][HTML] Impact of molecular diagnostic tests on diagnostic and treatment delays in tuberculosis: a systematic review and meta-analysis
Background Countries with high TB burden have expanded access to molecular diagnostic
tests. However, their impact on reducing delays in TB diagnosis and treatment has not been …
tests. However, their impact on reducing delays in TB diagnosis and treatment has not been …
Low body mass index as a predictor of sputum culture conversion and treatment outcomes among patients receiving treatment for multidrug-resistant tuberculosis in …
Background A low body mass index (BMI) at the start of treatment for rifampicin-or multidrug-
resistant tuberculosis (MDR/RR-TB) is associated with poor treatment outcomes and may …
resistant tuberculosis (MDR/RR-TB) is associated with poor treatment outcomes and may …
The Recent Transmission and Associated Risk Factor of Mycobacterium tuberculosis in Golmud City, China
Z Song, W He, X Cao, A Ma, P He, B Zhao… - Infection and Drug …, 2024 - Taylor & Francis
Background Tuberculosis (TB) remains a severe public health problem globally, and it is
essential to comprehend the transmission pattern to control tuberculosis. Herein, we …
essential to comprehend the transmission pattern to control tuberculosis. Herein, we …
[HTML][HTML] Genotypic and phenotypic characterization of Mycobacterium tuberculosis resistance against fluoroquinolones in the northeast of Iran
Background Fluoroquinolones are broad-spectrum antibiotics that are recommended, and
increasingly important, for the treatment of multidrug-resistant tuberculosis (MDR-TB) …
increasingly important, for the treatment of multidrug-resistant tuberculosis (MDR-TB) …
[HTML][HTML] Radiomics analysis of lung CT for multidrug resistance prediction in active tuberculosis: a multicentre study
Y Li, Z Xu, X Lv, C Li, W He, Y Lv, D Hou - European Radiology, 2023 - Springer
Abstract Objectives Multidrug-resistant TB (MDR-TB) is a severe burden and public health
threat worldwide. This study aimed to develop a radiomics model based on the tree-in-bud …
threat worldwide. This study aimed to develop a radiomics model based on the tree-in-bud …
[HTML][HTML] Strengthening resistance testing for tuberculosis in India-Investment cost, throughput, and efficiency of new laboratories
S Bashir, S Sarin, SS Chadha, A Kalra… - Tuberculosis, 2022 - Elsevier
A lack of laboratory capacity for drug-resistant tuberculosis (DR-TB) testing is a major barrier
to DR-TB control. To overcome this barrier, the Central Tuberculosis Division (CTD), Ministry …
to DR-TB control. To overcome this barrier, the Central Tuberculosis Division (CTD), Ministry …
Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs Among Mycobacterium tuberculosis by a Reverse Dot Blot Hybridization Assay
G Li, Q Guo, H Liu, L Wan, Y Jiang, M Li… - Infection and Drug …, 2020 - Taylor & Francis
Background Reliable and timely determination of second-line drug resistance is essential for
early initiation effective anti-tubercular treatment among multi-drug resistant (MDR) patients …
early initiation effective anti-tubercular treatment among multi-drug resistant (MDR) patients …
Exploring Diagnostic Methods for Drug-Resistant Tuberculosis: A Comprehensive Overview
A Sanchini, A Lanni, F Giannoni, A Mustazzolu - 2024 - preprints.org
Despite available global efforts and funding, Tuberculosis (TB) continues to affect a
considerable number of patients worldwide. Policy makers and stakeholders set clear goals …
considerable number of patients worldwide. Policy makers and stakeholders set clear goals …
[HTML][HTML] Status of Universal Drug Susceptibility Testing in Pulmonary Tuberculosis Patients Initiated on Treatment in an Urban Setting, South India
B Velayutham, L Jayabal, B Watson… - Indian Journal of …, 2023 - journals.lww.com
Results: The CBNAAT result was available for 1628 (82.6%) of the 1970 smear-positive PTB
patients. Non-availability of CBNAAT results was significantly higher among the older age …
patients. Non-availability of CBNAAT results was significantly higher among the older age …